Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Conmed ( (CNMD) ) has issued an announcement.
On January 27, 2025, Andrew Moller began his role as Vice President, Corporate Controller at CONMED Corporation, a company involved in the medical technology industry. By April 1, 2025, Moller was appointed as the Principal Accounting Officer, succeeding Todd W. Garner in this role. Additionally, Kimberly A. Lockwood was promoted to Senior Director of Financial Reporting. Moller brings extensive experience from his previous roles at Smith & Nephew plc and Stanley Black & Decker, enhancing CONMED’s leadership team.
More about Conmed
YTD Price Performance: -11.45%
Average Trading Volume: 486,167
Technical Sentiment Signal: Buy
Current Market Cap: $1.87B
For an in-depth examination of CNMD stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue